<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00681642</url>
  </required_header>
  <id_info>
    <org_study_id>200702037R</org_study_id>
    <nct_id>NCT00681642</nct_id>
  </id_info>
  <brief_title>Corneal Epithelial Wound Healing Difference Between Human Autoserum and Cord Blood Serum</brief_title>
  <official_title>Phase 1 Study of Comparison of the Effects on Promoting Corneal Epithelial Wound Healing Between Human Autoserum and Cord Blood Serum—in Vitro Cell Culture Experiment</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Taiwan University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Taiwan University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Human serum eye drops have been successfully used in the treatment of severe ocular surface
      disorders and the enhancement of corneal wound healing. Umbilical cord serum is also proven
      to be effective in treatment of dry eye and persistent corneal epithelial defects. However,
      there are limited studies comparing the corneal epithelial wound healing promoting effects
      between these two blood derived products. The purpose of this study is to test the corneal
      epithelial wound healing promoting effects between auto serum and human cord blood serum.
      Primary cultured bovine corneal epithelial cells were used as the model to investigate wound
      healing, cell proliferation and migration by means of scratch corneal wound healing assay
      evaluation, MTS assay and Boyden chamber migration assay in response to human serum and
      umbilical cord serum. The concentrations of EGF, TGF-β1, and fibronectin were also compared
      between human serum and umbilical cord serum with ELISA kits.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2007</start_date>
  <completion_date type="Actual">March 2008</completion_date>
  <primary_completion_date type="Actual">March 2008</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Cell proliferation</measure>
    <time_frame>1 week</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cell migration</measure>
    <time_frame>1 week</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">7</enrollment>
  <condition>Corneal Epithelial Wound Healing</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <description>Corneal epithelial tissue with wound cultured in human autoserum</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <description>Corneal epithelial tissue with wound cultured in umbilical cord serum</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Healthy pregnant women underwent smooth cesarean section during labor Healthy blood donor
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy pregnant women

          -  Cesarean section for labor

          -  Complete placenta with umbilical cord retained

          -  Healthy individual

        Exclusion Criteria:

          -  The retained placenta and umbilical cord were not complete

          -  Individual with anemia or other hematologic disorder unsuitable for blood donation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Wei-Li Chen, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>National Taiwan University Hospital, department of Ophthalmology</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>National Taiwan University Hospital, department of Ophthalmology</name>
      <address>
        <city>Taipei</city>
        <zip>10047</zip>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <reference>
    <citation>del Castillo JM, de la Casa JM, Sardiña RC, Fernández RM, Feijoo JG, Gómez AC, Rodero MM, Sánchez JG. Treatment of recurrent corneal erosions using autologous serum. Cornea. 2002 Nov;21(8):781-3.</citation>
    <PMID>12410036</PMID>
  </reference>
  <reference>
    <citation>Fox RI, Chan R, Michelson JB, Belmont JB, Michelson PE. Beneficial effect of artificial tears made with autologous serum in patients with keratoconjunctivitis sicca. Arthritis Rheum. 1984 Apr;27(4):459-61.</citation>
    <PMID>6712760</PMID>
  </reference>
  <reference>
    <citation>Geerling G, Maclennan S, Hartwig D. Autologous serum eye drops for ocular surface disorders. Br J Ophthalmol. 2004 Nov;88(11):1467-74. Review.</citation>
    <PMID>15489495</PMID>
  </reference>
  <reference>
    <citation>Goto E, Shimmura S, Shimazaki J, Tsubota K. Treatment of superior limbic keratoconjunctivitis by application of autologous serum. Cornea. 2001 Nov;20(8):807-10.</citation>
    <PMID>11685056</PMID>
  </reference>
  <reference>
    <citation>Poon AC, Geerling G, Dart JK, Fraenkel GE, Daniels JT. Autologous serum eyedrops for dry eyes and epithelial defects: clinical and in vitro toxicity studies. Br J Ophthalmol. 2001 Oct;85(10):1188-97.</citation>
    <PMID>11567963</PMID>
  </reference>
  <reference>
    <citation>Tsubota K, Goto E, Fujita H, Ono M, Inoue H, Saito I, Shimmura S. Treatment of dry eye by autologous serum application in Sjögren's syndrome. Br J Ophthalmol. 1999 Apr;83(4):390-5.</citation>
    <PMID>10434857</PMID>
  </reference>
  <reference>
    <citation>Tsubota K, Goto E, Shimmura S, Shimazaki J. Treatment of persistent corneal epithelial defect by autologous serum application. Ophthalmology. 1999 Oct;106(10):1984-9.</citation>
    <PMID>10519596</PMID>
  </reference>
  <reference>
    <citation>Tsubota K, Higuchi A. Serum application for the treatment of ocular surface disorders. Int Ophthalmol Clin. 2000 Fall;40(4):113-22. Review.</citation>
    <PMID>11064861</PMID>
  </reference>
  <reference>
    <citation>Tsubota K, Satake Y, Ohyama M, Toda I, Takano Y, Ono M, Shinozaki N, Shimazaki J. Surgical reconstruction of the ocular surface in advanced ocular cicatricial pemphigoid and Stevens-Johnson syndrome. Am J Ophthalmol. 1996 Jul;122(1):38-52.</citation>
    <PMID>8659597</PMID>
  </reference>
  <reference>
    <citation>Tsubota K, Shimazaki J. Surgical treatment of children blinded by Stevens-Johnson syndrome. Am J Ophthalmol. 1999 Nov;128(5):573-81.</citation>
    <PMID>10577524</PMID>
  </reference>
  <reference>
    <citation>Yoon KC, Heo H, Jeong IY, Park YG. Therapeutic effect of umbilical cord serum eyedrops for persistent corneal epithelial defect. Korean J Ophthalmol. 2005 Sep;19(3):174-8.</citation>
    <PMID>16209277</PMID>
  </reference>
  <reference>
    <citation>Yoon KC, Im SK, Park YG, Jung YD, Yang SY, Choi J. Application of umbilical cord serum eyedrops for the treatment of dry eye syndrome. Cornea. 2006 Apr;25(3):268-72.</citation>
    <PMID>16633024</PMID>
  </reference>
  <reference>
    <citation>Young AL, Cheng AC, Ng HK, Cheng LL, Leung GY, Lam DS. The use of autologous serum tears in persistent corneal epithelial defects. Eye (Lond). 2004 Jun;18(6):609-14.</citation>
    <PMID>15184926</PMID>
  </reference>
  <verification_date>December 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 19, 2008</study_first_submitted>
  <study_first_submitted_qc>May 19, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 21, 2008</study_first_posted>
  <last_update_submitted>January 6, 2011</last_update_submitted>
  <last_update_submitted_qc>January 6, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 10, 2011</last_update_posted>
  <responsible_party>
    <name_title>Wei-Li Chen, MD, PhD, Assistant Professor</name_title>
    <organization>National Taiwan University Hospital, department of Ophthalmology</organization>
  </responsible_party>
  <keyword>Corneal epithelial wound</keyword>
  <keyword>Human autoserum</keyword>
  <keyword>Cord blood</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Wounds and Injuries</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

